Pfizer results, outlook boosted by vaccine demand

Demand for the Pfizer-BioNTech COVID-19 vaccine is so strong that Pfizer expects the product to make up more than one-third of this year's total companywide sales after quarterly results beat and it raised full-year guidance. Conway G. Gittens reports

Multimedia

Most Popular Videos